(Q35876121)

10 August 2017

1 reference

title

Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine (English)

1 reference

10 August 2017

1

Gerhard Eisenbrand

1 reference

10 August 2017

Frankie Hippe

2

1 reference

10 August 2017

Sandra Jakobs

series ordinal

3

1 reference

10 August 2017

Stephan Muehlbeyer

series ordinal

4

1 reference

10 August 2017

language of work or name

1 reference

31 August 2004

1 reference

Journal of Cancer Research and Clinical Oncology

10 August 2017

published in

1 reference

10 August 2017

volume

130

1 reference

10 August 2017

issue

11

1 reference

10 August 2017

page(s)

627-635

1 reference

Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation

10 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-004-0579-2

Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos

21 January 2018

1 reference

12 December 2020

Chemical inhibitors of cyclin-dependent kinases

1 reference

12 December 2020

Highlight on the studies of anticancer drugs derived from plants in China

1 reference

12 December 2020

The E2F transcription factors: key regulators of cell proliferation

1 reference

12 December 2020

Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

1 reference

12 December 2020

CDK inhibition and cancer therapy

1 reference

12 December 2020

Cyclin-dependent kinases: engines, clocks, and microprocessors

1 reference

12 December 2020

Beta-catenin: a key mediator of Wnt signaling

1 reference

12 December 2020

Cyclin-dependent kinase inhibitors for treating cancer

1 reference

12 December 2020

New functional activities for the p21 family of CDK inhibitors

1 reference

12 December 2020

ATP-site directed inhibitors of cyclin-dependent kinases.

1 reference

12 December 2020

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

1 reference

12 December 2020

Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest

1 reference

12 December 2020

The retinoblastoma protein and cell cycle control

1 reference

12 December 2020

E2F: a nodal point in cell cycle regulation

1 reference

12 December 2020

Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.

1 reference

12 December 2020

Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4.

1 reference

12 December 2020

Inhibitors of serine/threonine kinases

1 reference

12 December 2020

Preclinical and clinical development of cyclin-dependent kinase modulators

1 reference

12 December 2020

The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction

1 reference

12 December 2020

CDK inhibitors: positive and negative regulators of G1-phase progression

1 reference

12 December 2020

Role of pRB dephosphorylation in cell cycle regulation

1 reference

12 December 2020

Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?

1 reference

12 December 2020

Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation

1 reference

12 December 2020

Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization

1 reference

12 December 2020

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

12 December 2020

To cycle or not to cycle: a critical decision in cancer.

1 reference

12 December 2020

The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3

1 reference

12 December 2020

Tau in Alzheimer's disease.

1 reference

12 December 2020

The structure-based design of ATP-site directed protein kinase inhibitors

1 reference

12 December 2020

Inhibitor binding to active and inactive CDK2: the crystal structure of CDK2-cyclin A/indirubin-5-sulphonate

1 reference

12 December 2020

Small-molecule inhibitors of cyclin-dependent kinases: molecular tools and potential therapeutics.

1 reference

12 December 2020

Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells

1 reference

12 December 2020

Distinct roles for cyclin-dependent kinases in cell cycle control

1 reference

12 December 2020

Rb function in cell-cycle regulation and apoptosis

1 reference

12 December 2020

The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism

1 reference

12 December 2020

Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines

1 reference

12 December 2020

Studies on the antineoplastic action and toxicity of synthetic indirubin (author's transl)

1 reference

12 December 2020

10.1007/S00432-004-0579-2

Identifiers

DOI

1 reference

10 August 2017

1 reference